Clinical trials
-
Point-of-care intervention to address financial hardship in families facing pediatric cancer -
Genomic-Risk Stratified Txs for Unfavorable Intermediate Risk Prostate Cancer (Guidance) This phase III trial uses the Decipher risk score to guide intensification (for higher Decipher gene risk) or de-intensification (for low Decipher gene risk) of treatment to better match therapies to an individual patient's cancer aggressiveness.…
- Investigator
- Brian H Ramnaraign
- Ages
- 18 Years - N/A
- Sexes
- Male
-
Postoperative or Salvage RT for Node Negative Prostate Cancer Following Radical Prostatectomy The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.
- Investigator
- Randal H Henderson
- Ages
- 18 Years - N/A
- Sexes
- Male
-
Phase I/II Study of Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patie Patients with breast cancer are commonly treated with taxane chemotherapy. Some very common side effects of taxanes, such as anemia and peripheral neuropathy, are often as not well addressed during treatment, resulting in dose reductions, dose…
- Investigator
- Coy Heldermon
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
DoD Mastectomy Breast cancer is the most common type of cancer in women. Removal of the breast, called "mastectomy", is performed either when there is cancer-or an increased risk of cancer-in the breast. This can result in a lot of pain during the months after…
- Investigator
- Cameron R Smith
- Ages
- 18 Years - N/A
- Sexes
- All
-
PAN009-18 (PC04): Protons for Unresectable, Borderline Resectable, or Medically Inoperable Panc The prognosis for patients with localized pancreatic adenocarcinoma who are not surgical candidates is poor. Patients characterized as having "borderline resectable" disease treated with preoperative chemo-radiotherapy fair somewhat better *…
- Investigator
- Romaine C Nichols
- Ages
- 18 Years - N/A
- Sexes
- All
-
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors This phase II trial studies the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated pancreatic neuroendocrine tumors. Chemotherapy drugs, such as capecitabine and temozolomide, work in…
- Investigator
- Brian H Ramnaraign
- Ages
- 18 Years - N/A
- Sexes
- All
-
NRG-BR009: Testing the addition of chemo to SOC in breast cancer patients at high risk of recurrence This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal,…
- Investigator
- Karen Daily
- Ages
- 18 Years - 60 Years
- Sexes
- Female
-
Compare Chemo Before and After Surgery vs After Surgery Alone for the TX of Gallbladder Cancer This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients with stage II-III gallbladder cancer. Chemotherapy drugs, such as gemcitabine and…
- Investigator
- Ibrahim Nassour
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 * early breast cancer with intermediate or high risk for disease recurrence who completed definitive…
- Investigator
- Karen Daily
- Ages
- 18 Years - 130 Years
- Sexes
- All